Multiple Sclerosis Clinical Trial
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Summary
The purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).
Eligibility Criteria
Inclusion Criteria:
Participant has diagnosis of relapsing remitting multiple sclerosis (RRMS) or secondary-progressive multiple sclerosis (SPMS) with relapses within the past 24 months.
Participant has cranial magnetic resonance imaging (MRI) demonstrating lesion(s) consistent with multiple sclerosis (MS).
Participant has evidence of physical disability according to Expanded Disability Status Scale (EDSS) or Timed 25-Foot Walk (T25FW) or 9-Hole Peg Test.
Exclusion Criteria:
- Participants must not have experienced or be recovering from a clinical MS relapse within 6 months of Screening.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 49 Locations for this study
Birmingham Alabama, 35233, United States
Phoenix Arizona, 85013, United States
Berkeley California, 94705, United States
Carlsbad California, 92011, United States
Hanford California, 93230, United States
Irvine California, 92697, United States
Palo Alto California, 94304, United States
Sacramento California, 95817, United States
San Francisco California, 94143, United States
Aurora Colorado, 80045, United States
Fort Collins Colorado, 80528, United States
Chicago Illinois, 60637, United States
Indianapolis Indiana, 46202, United States
Lenexa Kansas, 66214, United States
Baton Rouge Louisiana, 70810, United States
New Orleans Louisiana, 70121, United States
Baltimore Maryland, 21225, United States
Lutherville Maryland, 21093, United States
Boston Massachusetts, 02114, United States
Farmington Hills Michigan, 48334, United States
Owosso Michigan, 48867, United States
Chaska Minnesota, 55318, United States
Saint Louis Missouri, 63110, United States
Saint Louis Missouri, 63131, United States
Las Vegas Nevada, 89106, United States
Oklahoma City Oklahoma, 73104, United States
Portland Oregon, 97225, United States
Philadelphia Pennsylvania, 19107, United States
Franklin Tennessee, 37064, United States
Franklin Tennessee, 37067, United States
Johnson City Tennessee, 37604, United States
Dallas Texas, 75243, United States
Houston Texas, 77030, United States
Lubbock Texas, 79410, United States
Round Rock Texas, 78681, United States
Alexandria Virginia, 22310, United States
Kirkland Washington, 98034, United States
Seattle Washington, 98101, United States
Seattle Washington, 98122, United States
Seattle Washington, 98133, United States
Morgantown West Virginia, 26506, United States
Milwaukee Wisconsin, 53226, United States
Vancouver British Columbia, V6T 1, Canada
London Ontario, N6A 5, Canada
Ottawa Ontario, K1H 8, Canada
Toronto Ontario, M5B 1, Canada
Greenfield Park Quebec, J4V 2, Canada
Montreal Quebec, H2X 0, Canada
Montreal Quebec, H3A 2, Canada
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.